These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24382384)

  • 1. At the tipping point for epigenetic therapies in cancer.
    Jones PA
    J Clin Invest; 2014 Jan; 124(1):14-6. PubMed ID: 24382384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics and oncology.
    Mummaneni P; Shord SS
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological targeting of the cancer epigenome.
    Mabe NW; Perry JA; Malone CF; Stegmaier K
    Nat Cancer; 2024 Jun; 5(6):844-865. PubMed ID: 38937652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors.
    Kumar A; Emdad L; Fisher PB; Das SK
    Adv Cancer Res; 2023; 158():73-161. PubMed ID: 36990539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA demethylating agents and epigenetic therapy of cancer.
    Mani S; Herceg Z
    Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the cancer epigenome for therapy.
    Jones PA; Issa JP; Baylin S
    Nat Rev Genet; 2016 Sep; 17(10):630-41. PubMed ID: 27629931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment.
    Shirbhate E; Singh V; Jahoriya V; Mishra A; Veerasamy R; Tiwari AK; Rajak H
    Eur J Med Chem; 2024 Jan; 263():115938. PubMed ID: 37989059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenome-based personalized medicine in human cancer.
    Yan W; Herman JG; Guo M
    Epigenomics; 2016 Jan; 8(1):119-33. PubMed ID: 26344672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic therapy for solid tumors: from bench science to clinical trials.
    Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
    Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy.
    Myasoedova VA; Sukhorukov V; Grechko AV; Zhang D; Romanenko E; Orekhov V; Orekhov AN
    Curr Pharm Des; 2019; 25(6):635-641. PubMed ID: 30950345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the potential of epigenetic therapy to target solid tumors.
    Ahuja N; Easwaran H; Baylin SB
    J Clin Invest; 2014 Jan; 124(1):56-63. PubMed ID: 24382390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
    Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
    Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer epigenetics.
    Laird PW
    Hum Mol Genet; 2005 Apr; 14 Spec No 1():R65-76. PubMed ID: 15809275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
    Bayo J; Dalvi MP; Martinez ED
    Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of epigenetic therapy in solid tumours--lessons from the past.
    Azad N; Zahnow CA; Rudin CM; Baylin SB
    Nat Rev Clin Oncol; 2013 May; 10(5):256-66. PubMed ID: 23546521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions.
    Lin J; Wang C; Kelly WK
    Semin Oncol; 2013 Jun; 40(3):393-401. PubMed ID: 23806502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promise and failures of epigenetic therapies for cancer treatment.
    Bojang P; Ramos KS
    Cancer Treat Rev; 2014 Feb; 40(1):153-69. PubMed ID: 23831234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.